News Briefs Boston Scientific agrees to buy VC-backed Augmenix for up to $600 mln Alastair Goldfisher - 7 September 2018 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
